| BCBS Kansas | Zynteglo (betibeglogene autotemcel) Medical Drug Criteria Program Summary | 2022-11-15 |
| Medicare Palmetto | Billing and Coding: Guidance for Anti-Inhibitor Coagulant Complex (AICC) National Coverage Determination (NCD) 110.3 (56065) | 2022-11-15 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Treatment of Malignant Skin Lesions | 2022-11-14 |
| BCBS Highmark NY and West NY | Treatment of Malignant Skin Lesions | 2022-11-14 |
| BCBS Highmark Delaware | Treatment of Malignant Skin Lesions | 2022-11-14 |
| BCBS Highmark West Virginia | Treatment of Malignant Skin Lesions | 2022-11-14 |
| Medicare CGS | Transcutaneous Electrical Nerve Stimulators (TENS) - Policy Article (52520) | 2022-11-11 |
| Medicare Noridian | Transcutaneous Electrical Nerve Stimulators (TENS) - Policy Article (52520) | 2022-11-11 |
| BCBS Kansas | Contrast-Enhanced Coronary Computed Tomography Angiography (CCTA) for Coronary Artery Evaluation | 2022-11-09 |
| Wellcare New Jersey Medicaid Clinical | Gastrointestinal Pathogen Nucleic Acid Detection Panel | 2022-11-01 |